Immunovaccine Announces Positive Interim Phase 1 Data for DepoVax(TM)-Based Respiratory Syncytial Virus Vaccine Candidate
HALIFAX, NOVA SCOTIA–(Marketwired – July 6, 2016) – Immunovaccine Inc. (“Immunovaccine” or the “company”) (TSX:IMV)(OTCQX:IMMVF), a clinical stage [...]